Blood Advances
Publisher: Elsevier · ISSN 2473-9529 · 99 articles
- Omission of Radiation Therapy is Associated with Inferior Disease Control in High Risk Early-Stage Hodgkin Lymphoma:
- Idiopathic Multicentric Castleman Disease Unresponsive to One IL-6 Inhibitor May Respond to Another IL-6 Inhibitor
- Active Surveillance of JAK2V617F Clonal Hematopoiesis Toward Myeloproliferative Neoplasms
- Racial and Ethnic Differences in the Incidence of Langerhans Cell Histiocytosis Across the Age Spectrum
- CD19-CD28 costimulatory bispecific antibody plus glofitamab in R/R B-NHL: a phase 1 dose-escalation study
- Interpreting recurrence estimates in thrombophilia
- Characterizing clinical heterogeneity by whole-genome sequencing of 591 patients with Hemoglobin H disease
- Cytoreduction for MPN-associated splanchnic vein thrombosis
- Blinatumomab for pediatric B-ALL in LMICs: promise or peril?
- Salvage at molecular relapse: many paths, few signposts
- Systematic review and meta-analysis of hypersensitivity reactions after high-dose IV iron
- Diagnostic accuracy of fat pad sampling and bone marrow biopsy for AL amyloidosis: a systematic review and meta-analysis
- Thrombin-antithrombin complex and fibrinogen predict microangiopathic acute kidney injury in patients with traumatic injuries
- A phase 2a randomized study to evaluate sapablursen in patients with non-transfusion-dependent β-thalassemia intermedia
- Teclistamab and daratumumab immune-based doublet therapy for relapsed/refractory multiple myeloma: the TRIMM-2 study
- Real-world implementation, feasibility and early effectiveness of blinatumomab for pediatric B-ALL in lower-middle-income countries
- Efficacy and safety of thalidomide (1 vs 2 mg/kg per day) in transfusion-dependent thalassemia: a noninferiority trial
- Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: results from the ACCESS trial
- Phase 1, open-label, multicenter study of sovleplenib (HMPL-523) in patients with relapsed or refractory lymphoma
- PhenX Toolkit measurement protocols for sickle cell disease pain
- Peripheral CD8+ T-cell clonality and NK-cell expansion mark early response to mosunetuzumab in indolent B-cell lymphoma
- Cytokine concentrations in pediatric primary mediastinal large B-cell lymphoma correlate with disease extent and outcome
- Association between patient-reported symptoms and clinical outcomes in R/R CLL
- Nodal marginal zone lymphoma: genetic analysis and the differential diagnosis from other small B-cell lymphomas
- Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis
- Relationship between salvage strategy and outcomes in patients with CBF or NPM1-mutated AML and first molecular relapse
- A CRISPR-based humanized model reveals a cooperative role of STAG2 loss in familial GATA2-deficient MDS progression
- Murine model for congenital dyserythropoietic anemia type I
- Nonanemic iron deficiency in pregnancy: a cross-sectional study of prevalence and predictors
- Impact of cytoreductive therapy in myeloproliferative neoplasm–associated splanchnic vein thrombosis